SCHEMBL10620883

SCHEMBL10620883

Brc1ccc2c(c1)N=C(N1CCN(c3ccccc3)CC1)c1cccc3c1N2CC3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 10/20 0.39
▸ DRD1 P21728 10/20 0.39
▸ HRH4 Q9H3N8 2/20 0.39
▸ DRD4 P21917 2/20 0.38
▸ MAPK1 P28482 4/20 0.36
▸ MAPT P10636 4/20 0.36
▸ LMNA P02545 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ FGB P02675 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ DHFR P00374 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ GFER P55789 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10623807 0.89 DRD2 (0.47) DRD2DRD1HRH4DRD4MAPK1
SCHEMBL10623795 0.88 MEN1 (0.44) DRD2DRD1HRH4DRD4MAPK1
SCHEMBL10670880 0.87 MAPT (0.50) DRD2DRD1DRD4MAPTLMNA
SCHEMBL10623484 0.86 DRD2 (0.36) DRD2DRD1HRH4DRD4MAPK1
SCHEMBL10621376 0.84 DRD2 (0.36) DRD2DRD1HRH4DRD4MAPK1
SCHEMBL10620839 0.84 DRD2 (0.45) DRD2DRD1HRH4DRD4
SCHEMBL10623780 0.83 DRD2 (0.45) DRD2DRD1HRH4DRD4MAPK1
SCHEMBL10621517 0.80 MAPT (0.53) DRD2DRD1MAPK1MAPTLMNA
SCHEMBL10625744 0.77 DRD2 (0.42) DRD2DRD1HRH4DRD4ADRA2A
SCHEMBL10620893 0.77 HRH4 (0.50) DRD2DRD1HRH4DRD4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4761412-A Benzopyrrolobenzodiazepines and quinobenzodiazepines useful for the treatment of psychoses HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-08-02 — — US claimed
US-4663453-A Benzo[b]pyrrolo[3,2,1-jk][1,4]benzodiazepines having dopamine receptor activity HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1987-05-05 — — US claimed
US-4764616-A ANALGESIC, ANTIPHYCHOTIC HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-08-16 — — US disclosed
US-4761412-A Benzopyrrolobenzodiazepines and quinobenzodiazepines useful for the treatment of psychoses HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-08-02 — — US disclosed
US-4723007-A ANALGESICS, ANTIPSYCHOTIC AGENTS; INTERMEDIATES FOR PROCESSING HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-02-02 — — US disclosed
US-4723003-A ANTIPSYCHOTIC AGENTS, ANALGESICS HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-02-02 — — US disclosed
US-4663453-A Benzo[b]pyrrolo[3,2,1-jk][1,4]benzodiazepines having dopamine receptor activity HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1987-05-05 — — US disclosed
EP-0129692-A2 Dibenzodiazepin derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1985-01-02 — — EP disclosed
Send feedback